Future investigations evaluating mucosal taurine metabolism, as well as the activity of enzymes such as cysteine sulfinic acid decarboxylase, are warranted to clarify whether defects in this biosynthetic route directly contribute to systemic taurine reduction in IBD. Here, CSAD is linked to inflammatory bowel disease.